
|

|
National Pharma Audioconference: Examining the Latest Developments in Drug and Device CIAs How Corporate Integrity Agreements Continue to Reshape Compliance
Thursday, August 12, 2010
1:00 pm - 2:30 pm (Eastern)
12:00 pm - 1:30 pm (Central)
11:00 am - 12:30 pm (Mountain)
10:00 am - 11:30 am (Pacific)
|
|
AUDIOCONFERENCE FACULTY
|

Howard L. Dorfman, Esq.
Counsel, Ropes and Gray, Former Chief Legal Officer, Pharmaceutical Division, Bayer Healthcare LLC, Former Counsel, US Medicines Groups, Bristol-Myers Squibb, New York, NY |

Wendy C. Goldstein, Esq.
Partner and Chair, Pharmaceutical Industry Health Regulatory Practice Group, Epstein Becker & Green, PC, New York, NY
|

Lawrence P. Platkin, Esq.
Vice President and Compliance Officer, Bayer HealthCare LLC, Wayne, NJ |

Matthew Hay
Editor, Rx Compliance Report, Washington, DC (Moderator)
|
|
|
|
AUDIOCONFERENCE AGENDA
|
The Audioconference agenda is set forth in Eastern Daylight Time below:
|
|
1:00 pm |
Welcome and Introductions
Howard L. Dorfman, Esq.
|
|
1:05 pm |
Discussion of Emerging Risk Areas
Overview of CIAs and the Enforcement Landscape
- Overview of the current enforcement landscape
- General overview and update on recent settlements and CIAs
- The impact of healthcare reform legislation on the industry's compliance obligations related to fraud and abuse
- Review of other external factors impacting compliance obligations, including requirements promulgated by state legislatures, medical societies, and academic institutions
Howard L. Dorfman, Esq.
|
|
1:25 pm |
Key Elements of Recent CIAs and What They Mean
- How industry obligations are evolving based on the specific requirements of recent CIAs
Wendy Goldstein, Esq.
|
|
1:45 pm |
An In-house Perspective
- Analysis of what compliance organizations are required to do based on the specific requirements of a company's CIA
- How the teachings of the CIAs that follow impact a company's existing compliance obligations
Lawrence Platkin, Esq.
|
|
2:05 pm |
Questions & Answers
|
|
2:30 pm |
Audioconference Adjournment
|
|
|
SAVE THE DATE
|
ELEVENTH ANNUAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
Sponsored by Pharmaceutical Compliance Forum
Media Partner: Harvard Health Policy Review
October 20 - 22, 2010
Washington, DC
www.PharmaCongress.com
|
|
|
|

|
|

|